Literature DB >> 9867178

Use of contrast-enhanced MR imaging to detect sacroiliitis in children.

M Bollow1, J Braun, T Biedermann, S Mutze, S Paris, C Schauer-Petrowskaja, K Minden, S A Schmitz, M Schöntube, B Hamm.   

Abstract

PURPOSE: To verify the diagnostic value of contrast-enhanced MR imaging compared with conventional radiography in the diagnosis of sacroiliitis in children. DESIGN AND PATIENTS: Radiography and MR imaging of the sacroiliac joints were performed in 185 children subdivided into the following groups according to the modified European Spondyloarthropathy (SpA) Study Group (ESSG) criteria: group 1, undifferentiated spondyloarthropathy (uSpA) (n=53, 94.5% HLA-B27+); group 2, differentiated SpA (n=45, 93.3% HLA-B27+); group 3, patients with no signs of SpA other than oligoarthritis (n=39, 92.3% HLA-B27+); group 4, HLA-B27+ controls with various other non-SpA diagnoses (n=22); and group 5, HLA-B27-controls with various other non-SpA diagnoses (n=26). Radiographs were evaluated on the basis of the modified New York criteria independently by three experienced radiologists masked to the clinical data. In a second step, the same radiologists independently evaluated the MR images without knowledge of the clinical data and radiographic findings using the recently published criteria developed by our group. These criteria allow differentiation of acute and chronic inflammatory changes.
RESULTS: Radiography demonstrated sacroiliitis in 18 patients: 4 of 53 in group 1 (7.5%), 14 of 45 in group 2 (31%), but none in groups 3, 4 and 5. In contrast, MR imaging demonstrated acute and/or chronic sacroiliitis in 44 patients: 18 of 53 in group 1 (34%), 21 of 45 in group 2 (46.7%) and 5 of 39 in group 3 (12.8%), but none in groups 4 and 5. The percentage of sacroiliitis detected by MR imaging was significantly higher than that detected by radiography (P<0.001).
CONCLUSION: Contrast-enhanced MR imaging is a useful method for detecting sacroiliitis in children. Advantages of contrast-enhanced MR imaging compared with conventional radiography are a higher sensitivity due to the ability to document early and acute changes and the absence of radiation exposure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9867178     DOI: 10.1007/s002560050446

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  15 in total

Review 1.  Imaging of juvenile idiopathic arthritis.

Authors:  Karl Johnson
Journal:  Pediatr Radiol       Date:  2006-06-02

Review 2.  Juvenile spondyloarthritis.

Authors:  Sabrina Gmuca; Pamela F Weiss
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

3.  Evaluation and Treatment of Enthesitis-Related Arthritis.

Authors:  Pamela F Weiss
Journal:  Curr Med Lit Rheumatol       Date:  2013

4.  Reply.

Authors:  Pamela F Weiss; Arastoo Vossough; Nancy A Chauvin
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

Review 5.  Diagnosis and treatment of low back pain in the pediatric population.

Authors:  Alysha J Taxter; Nancy A Chauvin; Pamela F Weiss
Journal:  Phys Sportsmed       Date:  2014-02       Impact factor: 2.241

Review 6.  Imaging in Juvenile Spondyloarthritis.

Authors:  Pamela F Weiss; Nancy A Chauvin; Johannes Roth
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

Review 7.  New advances in juvenile spondyloarthritis.

Authors:  Shirley M L Tse; Ronald M Laxer
Journal:  Nat Rev Rheumatol       Date:  2012-04-10       Impact factor: 20.543

Review 8.  [Juvenile idiopathic arthritis--clinical subgroups and classification].

Authors:  K Minden; M Niewerth
Journal:  Z Rheumatol       Date:  2008-03       Impact factor: 1.372

Review 9.  [Grading sacroiliitis with emphasis on MRT-imaging].

Authors:  A G Jurik; N Egund
Journal:  Radiologe       Date:  2004-03       Impact factor: 0.635

10.  MRI findings of juvenile psoriatic arthritis.

Authors:  Edward Y Lee; Robert P Sundel; Susan Kim; David Zurakowski; Paul K Kleinman
Journal:  Skeletal Radiol       Date:  2008-07-02       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.